ScholarIQanswers from OpenAlex
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
PaperCitations, authors & open-access status
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma have?
ScholarIQcitation count
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma has 215 citations in the OpenAlex counts ScholarIQ stores.
When was Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma published?
ScholarIQyear
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma has 2011 year in the ScholarIQ index.
What is the open-access status of Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma?
ScholarIQoa status
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma has closed oa status in the ScholarIQ index.
What is the DOI of Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma?
ScholarIQdoi
The DOI for Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma is on the source record.
What is the PMID of Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma?
ScholarIQpmid
The PMID for Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma is on the source record.
What is the OpenAlex record for Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma?
ScholarIQopenalex
The OpenAlex for Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma is on the source record.